PART1 and non-small cell lung carcinoma: Investigations in non-small cell lung cancer and colorectal cancer also showed that overexpression of PART1 markedly promoted tumor cell proliferation and epithelial–mesenchymal transition in vitro and accelerated tumor growth in mouse xenograft models in vivo [46,47].